Ubs Group Ag Inspire Md, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Inspire Md, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 124,638 shares of NSPR stock, worth $311,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,638

Holding current value

$311,595

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.19 - $2.7 $272,957 - $336,522	124,638 New	124,638 $282,000
Q3 2024 Nov 14, 2024	BUY	$2.36 - $3.39 $5,576 - $8,010	2,363 New	2,363 $6,000
Q4 2023 Feb 09, 2024	BUY	$2.06 - $3.77 $2,406 - $4,403	1,168 New	1,168 $3,000
Q2 2023 Aug 11, 2023	BUY	$0.98 - $2.73 $79 - $221	81 Added 78.64%	184 $0
Q1 2023 May 12, 2023	SELL	$0.87 - $1.32 $904 - $1,372	-1,040 Reduced 90.99%	103 $0
Q4 2022 Feb 08, 2023	SELL	$0.81 - $1.44 $4,117 - $7,319	-5,083 Reduced 81.64%	1,143 $0
Q3 2022 Nov 10, 2022	BUY	$1.48 - $2.07 $2,542 - $3,556	1,718 Added 38.11%	6,226 $9,000
Q2 2022 Aug 10, 2022	BUY	$1.89 - $3.27 $4,394 - $7,602	2,325 Added 106.5%	4,508 $9,000
Q1 2022 May 16, 2022	BUY	$2.39 - $3.23 $5,217 - $7,051	2,183 New	2,183 $7,000

Others Institutions Holding NSPR

# of Institutions

Shares Held

11.7M

Call Options Held

Put Options Held

Nantahala Capital Management, LLC New Canaan, CT

2.32M
Shares

$5.8 Million
0.23% of portfolio
Orbimed Advisors LLC San Diego, CA

2.13M
Shares

$5.33 Million
0.17% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

1.89M
Shares

$4.72 Million
0.33% of portfolio
Marshall Wace, LLP London, X0

1.86M
Shares

$4.65 Million
0.01% of portfolio
Parkman Healthcare Partners LLC Stamford, CT

1.24M
Shares

$3.09 Million
0.38% of portfolio

View Full List

About InspireMD, Inc.

Ticker NSPR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,323,200
Market Cap $20.8M
Description
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...

More about NSPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account